239 related articles for article (PubMed ID: 28326948)
1. Rare presentation of intrathecal morphine withdrawal psychosis.
Aiyer R; Jain V; Bhatia A; Mekinulov B; Gungor S
Pain Manag; 2017 May; 7(3):171-173. PubMed ID: 28326948
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal symptoms in a patient receiving intrathecal morphine via an infusion pump.
Hu K; Connelly NR; Vieira P
J Clin Anesth; 2002 Dec; 14(8):595-7. PubMed ID: 12565119
[TBL] [Abstract][Full Text] [Related]
3. A case of uncommon withdrawal symptoms after a short period of spinal morphine administration.
Devulder J; Bohyn P; Castille F; De Laat M; Rolly G
Pain; 1996 Mar; 64(3):589-591. PubMed ID: 8783325
[TBL] [Abstract][Full Text] [Related]
4. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model.
Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A
J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581
[TBL] [Abstract][Full Text] [Related]
5. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
[TBL] [Abstract][Full Text] [Related]
6. A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion.
Singla A; Stojanovic MP; Chen L; Mao J
Anesth Analg; 2007 Dec; 105(6):1816-9, table of contents. PubMed ID: 18042887
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal Clonidine Pump Failure Causing Acute Withdrawal Syndrome With 'Stress-Induced' Cardiomyopathy.
Lee HM; Ruggoo V; Graudins A
J Med Toxicol; 2016 Mar; 12(1):134-8. PubMed ID: 26370679
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
9. [Opioid therapy for chronic noncancer pain: retrospective analysis of patients hospitalized for withdrawal].
Faure D; Giniès P; Eiden C; Portet L; Peyrière H
Therapie; 2013; 68(6):385-92. PubMed ID: 24356190
[TBL] [Abstract][Full Text] [Related]
10. Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.
Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Carroll I; Clark JD
J Addict Med; 2017; 11(5):342-349. PubMed ID: 28514235
[TBL] [Abstract][Full Text] [Related]
11. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
[TBL] [Abstract][Full Text] [Related]
12. Adolescent female with withdrawal psychosis following abrupt termination of ziprasidone.
Jacob MK; Ash P; Craighead WE
Eur Child Adolesc Psychiatry; 2012 Mar; 21(3):165-8. PubMed ID: 22249643
[TBL] [Abstract][Full Text] [Related]
13. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
[TBL] [Abstract][Full Text] [Related]
14. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
15. Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain-Individualized or Fixed Starting Dosage?
Bienek N; Maier C; Kaisler M; Michel-Lauter B; Schwarzer A; Meyer-Frießem CH
Pain Med; 2019 Dec; 20(12):2438-2449. PubMed ID: 30806672
[TBL] [Abstract][Full Text] [Related]
16. Drug-related side effects of long-term intrathecal morphine therapy.
Ruan X
Pain Physician; 2007 Mar; 10(2):357-66. PubMed ID: 17387357
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
Webster LR
Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
[TBL] [Abstract][Full Text] [Related]
18. [Transverse myelopathy as a complication following long-term intrathecal application of morphine in chronic back pain].
Schimpf J; Krakow K; Vehreschild N; Pohlmann-Eden B
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):506-9. PubMed ID: 10494374
[TBL] [Abstract][Full Text] [Related]
19. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
Jackson TP; Lonergan DF; Todd RD; Martin PR
Pain Pract; 2013 Apr; 13(4):297-309. PubMed ID: 22925591
[TBL] [Abstract][Full Text] [Related]
20. Persistent hiccup associated with intrathecal morphine infusion pump therapy.
Ruan X; Couch JP; Shah R; Wang F; Liu HN
Am J Phys Med Rehabil; 2007 Dec; 86(12):1019-22. PubMed ID: 18090443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
